Age-related macular degeneration (AMD) is the most common cause of blindness in the elderly. AMD progression is associated with alterations in inflammatory pathways and the immune system. A new study identifies a protective role for inflammasomes in AMD, suggesting that inflammasome activation might be manipulated as a potential therapeutic strategy for this condition (pages 791–798).
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Smith, W. et al. Ophthalmology 108, 697–704 (2001).
SanGiovanni, J.P. et al. Arch. Ophthalmol. 125, 671–679 (2007).
Klein, R.J. et al. Science 308, 385–389 (2005).
Crabb, J.W. et al. Proc. Natl. Acad. Sci. USA 99, 14682–14687 (2002).
Doyle, S.L. et al. Nat. Med. 18, 791–798 (2012).
Strowig, T., Henao-Mejia, J., Elinav, E. & Flavell, R. Nature 481, 278–286 (2012).
Hollyfield, J.G. et al. Nat. Med. 14, 194–198 (2008).
Martinon, F., Burns, K. & Tschopp, J. Mol. Cell 10, 417–426 (2002).
Medzhitov, R. Nature 454, 428–435 (2008).
Tuo, J. et al. FASEB J. 18, 1297–1299 (2004).
Combadière, C. et al. J. Clin. Invest. 117, 2920–2928 (2007).
Ambati, J. et al. Nat. Med. 9, 1390–1397 (2003).
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Chen, J., Smith, L. Protective inflammasome activation in AMD. Nat Med 18, 658–660 (2012). https://doi.org/10.1038/nm.2761